Please cite this article in press Milind D. Kate et al., A Review On Telmisartan Drug , Indo Am. J. P. Sci, 2024; 11 (07).

1. ADA] American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabet Care. 2002;25:199–201. [PubMed] [Google Scholar]
2. Basile J. Hypertension in the elderly: a review of the importance of systolic blood pressure elevation. J Clin Hypertens. 2002;4:108–12. [PMC free article] [PubMed] [Google Scholar]
3. Bjorklund K, Lind L, Zethelius B, et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107:1297–302. [PubMed] [Google Scholar]
4. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9. [PubMed] [Google Scholar]
5. Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. J Hum Hypertens. 2002;16(Suppl 2):S13–16. [PubMed] [Google Scholar]
6. Burnier M, Maillard M. The comparative pharmacology of angiotensin II receptor antagonists. Blood Press. 2001;10(Suppl 1):6–11. [PubMed] [Google Scholar]
7. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560–72. [PubMed] [Google Scholar]
8. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–15. [PubMed] [Google Scholar]
9. Cohen MC. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997;79:1512–16. [PubMed] [Google Scholar]
10. Cuspidi C, Meani S, Fusi V, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens. 2004;22:1991–8. [PubMed] [Google Scholar]
11. Eguchi K, Kario K, Shimada K. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. Am J Cardiol. 2003;92:621–4. [PubMed] [Google Scholar]
12. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29:992–6. [PubMed] [Google Scholar]
13. Gosse P, Ansoborlo P, Lemetayer P, et al. Left ventricular mass is better correlated with arising blood pressure than with office or occasional blood pressure. Am J Hypertens. 1997;10:505–10. [PubMed] [Google Scholar]
14. Gosse P, Cipriano C, Bemurat L, et al. Prognostic significance of blood pressure measured on rising. J Hum Hypertens. 2001;15:413–17. [PubMed] [Google Scholar]
15. Gosse P, Lasserre R, Minifie C, et al. Blood pressure surge on rising. J Hypertens. 2004;22:1113–18. [PubMed] [Google Scholar]
16. Gosse P, Neutel JM, Schumacher H, et al. Reduction of early morning blood pressure surge with telmisartan compared with ramipril in mild-to-moderate hypertensive patients. J Hypertens. 2005;23(Suppl 2):S375–6. [Google Scholar]
17. Guidelines Committee. European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–53. [PubMed] [Google Scholar]
18. Heyden S, Schneider KA. Obesity and hypertension: epidemiological aspects of the relationship. J Hum Hypertens. 1990;4:431–5. [PubMed] [Google Scholar]
19. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6. [PubMed] [Google Scholar]
20. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–19. [PubMed] [Google Scholar]
21. Lacourcière Y, Gil-Extremera B, Mueller O, et al. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension. Int J Clin Pract. 2003;57:273–9. [PubMed] [Google Scholar]
22. Lacourcière Y, Krzesinski JM, White WB, et al. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit. 2004a;9:203–10. [PubMed] [Google Scholar]
23. Lacourcière Y, Lenis J, Orchard R, et al. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit. 1998;3:295–302. [PubMed] [Google Scholar]
24. Lacourcière Y, Neutel J, Koval SE, et al. A prospective, randomized investigation of the safety and efficacy of telmisartan vs ramipril in mild-to-moderate hypertensives using ambulatory blood pressure monitoring. Hypertension. 2004b;44:576. [Google Scholar]
25. Lacourcière Y, Neutel J, Davidai G, et al. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Am J Hypertens. 2006;19:104–12. [PubMed] [Google Scholar]
26. Lefebvre J, Poirier L, Lacourcière Y. Methodology to determine duration of action for antihypertensive drugs. Ann Pharmacother. 2002;36:874–81. [PubMed] [Google Scholar]
27. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13. [PubMed] [Google Scholar]
28. Littlejohn T, Mroczek W, Marbury T, et al. A prospective, randomized, open-label trial comparing telmisartan 80 mg and valsartan 80 mg in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol. 2000;16:1123–32. [PubMed] [Google Scholar]
29. Mallion JM, Siché JP, Lacourcière Y, et al. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens. 1999;13:657–64. [PubMed] [Google Scholar]
30. Markham A, Goa KL. Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. Drugs. 1997;54:299–311. [PubMed] [Google Scholar]
31. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke. 1989;20:473–6. [PubMed] [Google Scholar]
32. Meredith PA. Angiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effect. Am J Cardiovasc Drugs. 2005;5:171–83. [PubMed] [Google Scholar]
33. Meredith PA, Elliott HL. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration. J Cardiovasc Pharmacol. 1994;23(Suppl 5):S26–30. [PubMed] [Google Scholar]
34. Motwani JG. Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension. J Renin Angiotensin Aldosterone Syst. 2002;3:72–8. [PubMed] [Google Scholar]
35. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315–22. [PubMed] [Google Scholar]
36. Neldam S, for the ATHOS Group Telmisartan + hydrochlorothiazide versus amlodipine + hydrochlorothiazide in older patients with predominantly systolic hypertension. J Hypertens. 2005;23(Suppl 2):S116. [Google Scholar]
37. Neutel JM, Littlejohn TW, Chrysant SGSA, et al. Telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension. Hypertens Res. 2005;28:555–63. [PubMed] [Google Scholar]
38. Nishimura T, Hashimoto J, Ohkubo T, et al. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Clin Exp Hypertens. 2005;27:477–89. [PubMed] [Google Scholar]
39. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–15. [PubMed] [Google Scholar]